AbCellera Announces Resignation of Board Member

Core Viewpoint - Peter Thiel intends to resign from AbCellera's Board of Directors for personal reasons, effective March 7, 2024, after serving since November 2020 [1][2] Company Summary - AbCellera is focused on advancing antibody drug discovery to deliver better medicines to patients more quickly, integrating expert teams, technology, and data science [3] - The company aims to provide innovative biotechs and leading pharmaceutical companies with a competitive advantage in drug development [3] Board Changes - Following Thiel's resignation, the size of AbCellera's Board of Directors will decrease from six to five members [2] - Dr. Andrew Lo will be appointed to the Nominating and Corporate Governance Committee effective March 7, 2024 [1]